Free Trial

Globus Medical (GMED) Competitors

Globus Medical logo
$83.10 +0.47 (+0.57%)
(As of 05:30 PM ET)

GMED vs. EW, IDXX, RMD, DXCM, STE, PODD, HOLX, BAX, MASI, and TFX

Should you be buying Globus Medical stock or one of its competitors? The main competitors of Globus Medical include Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), STERIS (STE), Insulet (PODD), Hologic (HOLX), Baxter International (BAX), Masimo (MASI), and Teleflex (TFX). These companies are all part of the "health care equipment" industry.

Globus Medical vs.

Edwards Lifesciences (NYSE:EW) and Globus Medical (NYSE:GMED) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, risk, valuation, profitability, community ranking, institutional ownership and dividends.

Edwards Lifesciences has a beta of 1.12, suggesting that its stock price is 12% more volatile than the S&P 500. Comparatively, Globus Medical has a beta of 1.19, suggesting that its stock price is 19% more volatile than the S&P 500.

Edwards Lifesciences received 768 more outperform votes than Globus Medical when rated by MarketBeat users. Likewise, 71.03% of users gave Edwards Lifesciences an outperform vote while only 67.87% of users gave Globus Medical an outperform vote.

CompanyUnderperformOutperform
Edwards LifesciencesOutperform Votes
1334
71.03%
Underperform Votes
544
28.97%
Globus MedicalOutperform Votes
566
67.87%
Underperform Votes
268
32.13%

Edwards Lifesciences has higher revenue and earnings than Globus Medical. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Edwards Lifesciences$6.31B6.93$1.40B$6.9310.70
Globus Medical$2.48B4.53$122.87M$0.67123.09

79.5% of Edwards Lifesciences shares are owned by institutional investors. Comparatively, 95.2% of Globus Medical shares are owned by institutional investors. 1.3% of Edwards Lifesciences shares are owned by company insiders. Comparatively, 18.5% of Globus Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Edwards Lifesciences has a net margin of 70.82% compared to Globus Medical's net margin of 3.69%. Edwards Lifesciences' return on equity of 20.76% beat Globus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Edwards Lifesciences70.82% 20.76% 15.27%
Globus Medical 3.69%9.98%7.92%

Edwards Lifesciences currently has a consensus price target of $79.40, indicating a potential upside of 7.05%. Globus Medical has a consensus price target of $94.55, indicating a potential upside of 14.64%. Given Globus Medical's stronger consensus rating and higher possible upside, analysts clearly believe Globus Medical is more favorable than Edwards Lifesciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Edwards Lifesciences
0 Sell rating(s)
15 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.42
Globus Medical
1 Sell rating(s)
2 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.67

In the previous week, Globus Medical had 10 more articles in the media than Edwards Lifesciences. MarketBeat recorded 27 mentions for Globus Medical and 17 mentions for Edwards Lifesciences. Edwards Lifesciences' average media sentiment score of 0.69 beat Globus Medical's score of 0.63 indicating that Edwards Lifesciences is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Edwards Lifesciences
5 Very Positive mention(s)
3 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Positive
Globus Medical
8 Very Positive mention(s)
1 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Edwards Lifesciences beats Globus Medical on 11 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GMED vs. The Competition

MetricGlobus MedicalSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$11.23B$4.30B$5.16B$19.10B
Dividend YieldN/A44.59%5.12%3.65%
P/E Ratio123.0925.0287.3240.98
Price / Sales4.5345.651,157.7917.50
Price / Cash22.9943.4043.2321.28
Price / Book2.817.034.785.29
Net Income$122.87M$13.64M$120.55M$989.88M
7 Day Performance0.94%-2.41%-1.55%-3.56%
1 Month Performance-2.66%-1.98%13.71%-5.11%
1 Year Performance53.66%37.58%28.65%11.06%

Globus Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GMED
Globus Medical
4.857 of 5 stars
$83.10
+0.6%
$94.55
+13.8%
+53.9%$11.32B$2.48B124.035,000
EW
Edwards Lifesciences
3.8666 of 5 stars
$73.84
+0.7%
$79.40
+7.5%
-1.3%$43.55B$6.00B10.7419,800
IDXX
IDEXX Laboratories
4.9718 of 5 stars
$432.35
+0.1%
$539.63
+24.8%
-25.6%$35.40B$3.84B41.6711,000
RMD
ResMed
4.5275 of 5 stars
$241.02
+1.0%
$227.91
-5.4%
+38.4%$35.38B$4.81B31.599,980Positive News
Gap Down
DXCM
DexCom
4.9155 of 5 stars
$76.42
-1.0%
$98.00
+28.2%
-34.5%$29.85B$3.95B46.229,600
STE
STERIS
4.9385 of 5 stars
$213.74
-0.2%
$262.50
+22.8%
-5.6%$21.10B$5.14B48.9118,179Positive News
PODD
Insulet
4.2312 of 5 stars
$265.75
-1.3%
$267.44
+0.6%
+23.3%$18.64B$1.70B46.123,000Positive News
HOLX
Hologic
4.6651 of 5 stars
$73.14
-0.7%
$89.50
+22.4%
+0.9%$16.60B$4.03B22.147,063
BAX
Baxter International
4.5385 of 5 stars
$29.56
-2.5%
$40.45
+36.9%
-23.1%$15.09B$15.06B149.2060,000Options Volume
MASI
Masimo
3.5801 of 5 stars
$177.11
+0.6%
$170.67
-3.6%
+43.6%$9.48B$2.04B121.485,200
TFX
Teleflex
4.8607 of 5 stars
$179.11
-0.6%
$259.00
+44.6%
-29.0%$8.32B$2.97B35.8114,500

Related Companies and Tools


This page (NYSE:GMED) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners